Mice lacking smooth muscle calponin display increased bone formation that is associated with enhancement of bone morphogenetic protein responses
暂无分享,去创建一个
Kenji Nakamura | M. Katsuki | K. Nakao | S. Mori | H. Yoshikawa | K. Takahashi | H. Yamamura | S. Taniguchi | K. Miyado | Katsuhito Takahashi | H. Yoshikawa | M. Sugimoto | K. Nakamura | N. Shibata | M. Sugimoto | Shunpei Taniguchi
[1] M. Tatsuta,et al. Expression of the smooth muscle calponin gene in human osteosarcoma and its possible association with prognosis , 1998, International journal of cancer.
[2] A. McMahon,et al. Noggin, cartilage morphogenesis, and joint formation in the mammalian skeleton. , 1998, Science.
[3] Jay X. Tang,et al. Cytoskeletal targeting of calponin in differentiated, contractile smooth muscle cells of the ferret , 1998, The Journal of physiology.
[4] Y. Kawakami,et al. Bone Morphogenetic Protein Signaling Is Required for Maintenance of Differentiated Phenotype, Control of Proliferation, and Hypertrophy in Chondrocytes , 1998, The Journal of cell biology.
[5] C. Zimmerman,et al. Smad Proteins Physically Interact with Calmodulin* , 1998, The Journal of Biological Chemistry.
[6] Kohei Miyazono,et al. TGF-β signalling from cell membrane to nucleus through SMAD proteins , 1997, Nature.
[7] S. Kuroda,et al. Regulation of Cross-linking of Actin Filament by IQGAP1, a Target for Cdc42* , 1997, The Journal of Biological Chemistry.
[8] D. DeRosier,et al. Evidence for a Conformational Change in Actin Induced by Fimbrin (N375) Binding , 1997, The Journal of cell biology.
[9] W. Lehman,et al. 3-D image reconstruction of reconstituted smooth muscle thin filaments containing calponin: visualization of interactions between F-actin and calponin. , 1997, Journal of molecular biology.
[10] L. Adam,et al. Calponin and Mitogen-activated Protein Kinase Signaling in Differentiated Vascular Smooth Muscle* , 1997, The Journal of Biological Chemistry.
[11] W. Ip,et al. Association of Calponin with Desmin Intermediate Filaments* , 1997, The Journal of Biological Chemistry.
[12] R. Grange,et al. Adenovirus‐mediated transfer of the smooth muscle cell calponin gene inhibits proliferation of smooth muscle cells and fibroblasts , 1997, FEBS letters.
[13] T. Fujii,et al. Interaction of chicken gizzard smooth muscle calponin with brain microtubules. , 1997, Journal of biochemistry.
[14] A. Reddi. BMPs: Actions in flesh and bone , 1997, Nature Medicine.
[15] P. Szymanski,et al. Localization of Protein Regions Involved in the Interaction between Calponin and Myosin* , 1997, The Journal of Biological Chemistry.
[16] M. Saraste,et al. Crystal structure of a calponin homology domain , 1997, Nature Structural Biology.
[17] A. Monsoro-Burq,et al. The role of bone morphogenetic proteins in vertebral development. , 1996, Development.
[18] N. Gusev,et al. Interaction of smooth muscle calponin and desmin , 1996, FEBS letters.
[19] Clifford J. Tabin,et al. Regulation of Rate of Cartilage Differentiation by Indian Hedgehog and PTH-Related Protein , 1996, Science.
[20] K. Tanaka,et al. Molecular cloning and characterization of human non-smooth muscle calponin. , 1996, Journal of biochemistry.
[21] P. Polakis,et al. IQGAP1, a calmodulin‐binding protein with a rasGAP‐related domain, is a potential effector for cdc42Hs. , 1996, The EMBO journal.
[22] David J. Anderson,et al. Alternative Neural Crest Cell Fates Are Instructively Promoted by TGFβ Superfamily Members , 1996, Cell.
[23] A. Buchwald,et al. Accumulation of Unphosphorylated Calponin in the Submembranous Cytoskeletons of Arachidonic Acid-stimulated Human Platelets , 1996, Thrombosis and Haemostasis.
[24] M. Gimona,et al. Expressing functional domains of mouse calponin: involvement of the region around alanine 145 in the actomyosin ATPase inhibitory activity of calponin. , 1996, Biochemistry.
[25] E. Olson,et al. Expression of the Smooth Muscle Cell Calponin Gene Marks the Early Cardiac and Smooth Muscle Cell Lineages during Mouse Embryogenesis (*) , 1996, The Journal of Biological Chemistry.
[26] E. Morrisey,et al. Developmental Pattern of Expression and Genomic Organization of the Calponin-h1 Gene , 1996, The Journal of Biological Chemistry.
[27] K. Takaoka,et al. Expression of bone morphogenetic protein‐4 mRNA during the process of bone formation in embryogenesis and fracture repair , 1996, Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society.
[28] K. Takahashi,et al. Calponin induces actin polymerization at low ionic strength and inhibits depolymerization of actin filaments. , 1995, The Biochemical journal.
[29] K. Miyazono,et al. Enhanced expression of type I receptors for bone morphogenetic proteins during bone formation , 1995, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[30] M. Saraste,et al. Does Vav bind to F‐actin through a CH domain? , 1995, FEBS letters.
[31] K. Miyazono,et al. Distinct spatial and temporal expression patterns of two type I receptors for bone morphogenetic proteins during mouse embryogenesis. , 1995, Endocrinology.
[32] H. Schluesener,et al. Immunolocalization of BMP-6, a novel TGF-beta-related cytokine, in normal and atherosclerotic smooth muscle cells. , 1995, Atherosclerosis.
[33] K. Watson,et al. Atherosclerotic calcification: relation to developmental osteogenesis. , 1995, The American journal of cardiology.
[34] K. Takahashi,et al. Agonist-induced redistribution of calponin in contractile vascular smooth muscle cells. , 1994, The American journal of physiology.
[35] M. Katsuki,et al. Gene replacement of the p53 gene with the lacZ gene in mouse embryonic stem cells and mice by using two steps of homologous recombination. , 1994, Biochemical and biophysical research communications.
[36] P. Weissberg,et al. High expression of genes for calcification-regulating proteins in human atherosclerotic plaques. , 1994, The Journal of clinical investigation.
[37] K. Takaoka,et al. Transient and localized expression of bone morphogenetic protein 4 messenger RNA during fracture healing , 1994, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[38] R. Green,et al. Cloning and expression of a novel acidic calponin isoform from rat aortic vascular smooth muscle. , 1994, The Journal of biological chemistry.
[39] J. Small,et al. Calponin and SM 22 as differentiation markers of smooth muscle: spatiotemporal distribution during avian embryonic development. , 1993, Differentiation; research in biological diversity.
[40] J. Small,et al. Mammalian calponin , 1993, FEBS letters.
[41] R. Larson,et al. Fusion of the dominant negative transcription regulator CHOP with a novel gene FUS by translocation t(12;16) in malignant liposarcoma , 1993, Nature Genetics.
[42] K. Watson,et al. Bone morphogenetic protein expression in human atherosclerotic lesions. , 1993, The Journal of clinical investigation.
[43] C. Kay,et al. Characterization of the smooth muscle calponin and calmodulin complex. , 1993, Biochemistry.
[44] T. Lints,et al. The hematopoietically expressed vav proto-oncogene shares homology with the dbl GDP-GTP exchange factor, the bcr gene and a yeast gene (CDC24) involved in cytoskeletal organization. , 1992, Oncogene.
[45] B. Nadal-Ginard,et al. Molecular cloning and sequence analysis of smooth muscle calponin. , 1991, The Journal of biological chemistry.
[46] V. Rosen,et al. Recombinant human bone morphogenetic protein-2 stimulates osteoblastic maturation and inhibits myogenic differentiation in vitro , 1991, The Journal of cell biology.
[47] J. Small,et al. Smooth muscle specific expression of calponin , 1990, FEBS letters.
[48] S. Winder,et al. Smooth muscle calponin. Inhibition of actomyosin MgATPase and regulation by phosphorylation. , 1990, The Journal of biological chemistry.
[49] K. Hiwada,et al. Vascular Smooth Muscle Calponin: A Novel Troponin T‐like Protein , 1988, Hypertension.
[50] K. Takahashi,et al. Isolation and characterization of a 34,000-dalton calmodulin- and F-actin-binding protein from chicken gizzard smooth muscle. , 1986, Biochemical and biophysical research communications.
[51] E. King,et al. Estimation of Plasma Phosphatase by Determination of Hydrolysed Phenol with Amino-antipyrine , 1954, Journal of clinical pathology.
[52] T. Hasegawa,et al. Histological and immunohistochemical diversities, and proliferative activity and grading in osteosarcomas. , 1997, Cancer detection and prevention.
[53] M. Gimona. Chapter 7 – Calponin , 1996 .